JEXT
"JEXT" is a word mark owned by ALK-Abelló A/S, filed at the CIPO on June 19, 2014. It is registered and covers classes 5 and 10.
- Status
- Registered
- Since June 17, 2019
- Filed
- June 19, 2014
- Registered
- June 17, 2019
- Expires
- June 17, 2029
- Application no.
- 1683422
- Registration no.
- TMA1025858
- Office
- CIPO
- Canadian Intellectual Property Office
- Mark type
- Word mark
- 2 classes
Who owns JEXT
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
ALK-Abelló A/S
Denmark
Representative
Deeth Williams Wall LLP
Deeth Williams Wall LLP
What the mark covers
The products and services JEXT is filed for, grouped by Nice class.
Pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations for immunotherapeutic purposes and pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma and respiratory allergic diseases; diagnostic preparations for medical purposes, namely, for the treatment, monitoring and diagnosing of allergies, asthma, rhinitis and repiratory diseases, diagnostic reagents and diagnostic testing materials for medical use, namely, for diagnosing, preventing and treating allergies, asthma, rhinitis and repiratory diseases; pharmaceutical preparations in the form of injectable pharmaceuticals, particularly adrenaline, for treatment of anaphylactic reactions; inhalers; medical devices, namely, injectors for treatment of anaphylactic reactions; hypodermic injectors and holders for hypodermic injectors; parts and fittings for all the aforesaid goods.; Pharmaceutical preparations in the form of injectable pharmaceuticals, particularly adrenaline, for treatment of anaphylactic reactions; apparatus and instruments containing pharmaceutical preparations, substances and medicines, particularly adrenaline, namely, injectors for the treatment of allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions; hypodermic injectors and holders for hypodermic injectors; parts and fittings for all the aforesaid goods.
Pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations for immunotherapeutic purposes and pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma and respiratory allergic diseases; diagnostic preparations for medical purposes, namely, for the treatment, monitoring and diagnosing of allergies, asthma, rhinitis and repiratory diseases, diagnostic reagents and diagnostic testing materials for medical use, namely, for diagnosing, preventing and treating allergies, asthma, rhinitis and repiratory diseases; pharmaceutical preparations in the form of injectable pharmaceuticals, particularly adrenaline, for treatment of anaphylactic reactions; inhalers; medical devices, namely, injectors for treatment of anaphylactic reactions; hypodermic injectors and holders for hypodermic injectors; parts and fittings for all the aforesaid goods.; Pharmaceutical preparations in the form of injectable pharmaceuticals, particularly adrenaline, for treatment of anaphylactic reactions; apparatus and instruments containing pharmaceutical preparations, substances and medicines, particularly adrenaline, namely, injectors for the treatment of allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions; hypodermic injectors and holders for hypodermic injectors; parts and fittings for all the aforesaid goods.
What has happened so far
Steps recorded by the CIPO, newest first.
- Registered
- Extension of Time; Online Request Date: 2018/11/15
- Extension of Time; Request Letter Date: 2018/05/30
- Extension of Time; Request Letter Date: 2017/11/21
- Extension of Time; Request Letter Date: 2017/05/18
- Allowance Notice Sent
- Allowed
- Advertised; Vol.63 Issue 3225
- Approved; APPROVED BY PROGRAM EX200M1
- Approval Notice Sent
10 earlier steps on the official record.
About JEXT
Who owns the trademark "JEXT"?
The CIPO trademark "JEXT" (application 1683422) is owned by ALK-Abelló A/S.
What is the status of "JEXT"?
Its status at the CIPO is: registered.
When was "JEXT" registered?
It was registered on June 17, 2019 and is due to expire on June 17, 2029.
Get this data via the API
Everything on this page comes from the Signa API. Pull JEXT and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019deb39-1734-7108-a847-42971d6bf1c1
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019deb39-1734-7108-a847-42971d6bf1c1",
"object": "trademark",
"mark_text": "JEXT",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "CA",
"application_number": "1683422",
"filing_date": "2014-06-19",
"nice_classes": [
5,
10
],
"owners": [
{
"name": "ALK-Abelló A/S",
"entity_id": "ent_019eb6f7-d7a6-7420-874f-900c24eb0227"
}
]
}